(MENAFN- Introspective Market Research) The Neurotechnology Market research delivers comprehensive research on the present stage of the market, covers market size with respect to assessment as sales volume, and provides a precise forecast of the market scenario over the estimated period. Also focuses on the product, application, manufacturers, suppliers, and regional segments of the market. Neurotechnology Market report research highlights market driving factors, an overview of the market growth, industry size, and market share. Subsequently Neurotechnology Market report depicts the constantly evolving needs of clients, vendors, and purchasers in different regions, it becomes simple to target specific market and generate large revenues in the global industry.
The Neurotechnology Market Is Expected To Grow At A Significant Growth Rate, And The Analysis Period Is 2022-2028, Considering The Base Year As 2021.
Neurotechnology refers to a branch of science, which is based on the activity of the brain and includes technologies, which are developed to enhance and repair functionality of the brain. Neurotechnology is used in research and development to analyse the brain's activity. Modernising neurotechnology helps in possibly resolving depression, sleep loss, over-activation, and many other disorders. Therapeutic applications can help with conditions such as epilepsy and degenerative motor disorders such as Parkinson's disease, Huntington 's disease, and ALS. Technological innovation in the field of neurotechnology may include approaches to the development and rehabilitation of a patient suffering neurological problems.
The Key Players Covered In The Neurotechnology Market Report Is:
• General Electric Company (The U.S)
• Siemens Healthineers (Germany)
• Koninklijke Philips N.V. (Netherlands)
• Toshiba Medical Systems Corporation (Japan)
• Shimadzu Corporation (Japan)
• Hitachi Medical Corporation (Japan)
• Elekta AB (Sweden)
• Tristan Technologies, Inc. (The U.S)
• Natus Medical Incorporated (The U.S)
• Magstim (UK), and other major players.
Request A Free Sample Of Neurotechnology Market Report:
Segmentation Of Neurotechnology Market:
In Market Segmentation By Communication Type, Neurotechnology Market Report Covers:
• Neurostimulation
• Imaging Modalities
• Neurological Implants
• Cranial Surface Measurement
• Others
In Market Segmentation By Vehicle Type, Neurotechnology Market Report Covers:
• Diagnostic Centers
• Ambulatory Surgical Centers
• Hospitals
• Clinics, Others
Market Segment By Regions And Countries Level Analysis:
• North America (U.S., Canada, Mexico)
• Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
• Asia-Pacific (China, India, Japan, Southeast Asia, Rest of APAC)
• Middle East & Africa (GCC Countries, South Africa, Rest of MEA)
• South America (Brazil, Argentina, Rest of South America)
If You Have Any Query Neurotechnology Market Report, Visit:
Covid-19 Impact Analysis On Neurotechnology Market
COVID-19 began in Wuhan (China) in December 2019 and has since rapidly grown around the globe. In terms of confirmed cases and reported deaths, the US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are among the countries that have been most severely impacted. Because of the lockdowns, travel restrictions, and business closures, COVID-19 has had an impact on the businesses and industries of numerous nations. The covid-19 has had a positive impact on the healthcare system. During the pandemic, the pharmaceutical industries engaged in research and development activity. Thus, growing demand for neurotechnology in the healthcare sector. Because of the covid-19 burden people suffering from memory disturbances, and migraines. The neurological symptoms include headaches, loss of taste, and smell, stroke, brain inflammation, sleep disorders, and delirium. Thus, the adoption of neurotechnology during the pandemic is increased. Henceforth COVID-19 has had a positive impact on the neurotechnology market.
Key Industry Development In The Neurotechnology Market
• In September 2021, Food and Drug Administration (FDA) Approves the Amplatzer Talisman Patent Foramen ovale (PFO) Occlusion System developed by Abbott for patients with recurrent ischemic stroke. This helps to develop the efficiency and effectiveness of the occlusion procedure in a faster and simpler manner.
• In April 2022, Natus Medical Inc. is acquired by ArchiMed, a leading investment company for the healthcare industry for USD 1.2 billion. The purpose of the acquisition is to deliver valuable services to its customers.
MENAFN26112022005314010651ID1105235313
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.